GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sunniva Inc (XCNQ:SNN) » Definitions » Pre-Tax Income

Sunniva (XCNQ:SNN) Pre-Tax Income : C$-41.82 Mil (TTM As of Sep. 2019)


View and export this data going back to 2018. Start your Free Trial

What is Sunniva Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Sunniva's pretax income for the three months ended in Sep. 2019 was C$-9.08 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2019 was C$-41.82 Mil. Sunniva's pretax margin was -169.32%.


Sunniva Pre-Tax Income Historical Data

The historical data trend for Sunniva's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunniva Pre-Tax Income Chart

Sunniva Annual Data
Trend Dec16 Dec17 Dec18
Pre-Tax Income
-6.89 -19.50 -29.36

Sunniva Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.11 -12.74 -4.35 -15.65 -9.08

Competitive Comparison of Sunniva's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Sunniva's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunniva's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sunniva's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Sunniva's Pre-Tax Income falls into.



Sunniva Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Sunniva's Pretax Income for the fiscal year that ended in Dec. 2018 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-28.082+0.381+-0.953+0+-0.702
=-29.36

Sunniva's Pretax Income for the quarter that ended in Sep. 2019 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-7.139+0.123+-2.061+0+0
=-9.08

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-41.82 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sunniva  (XCNQ:SNN) Pre-Tax Income Explanation

Sunniva's Pretax Margin for the quarter that ended in Sep. 2019 is calculated as

Pretax Margin=Pretax Income/Revenue
=-9.077/5.361
=-169.32%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sunniva Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Sunniva's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Sunniva (XCNQ:SNN) Business Description

Traded in Other Exchanges
N/A
Address
200 Burrard Street, 1200 Waterfront Centre, P.O Box 48600, Vancouver, BC, CAN, V7X 1T2
Sunniva Inc is vertically integrated medical cannabis company committed to delivering safe, low-cost, high-quality products and services at scale. The company is focused on the cultivation, production and distribution of therapeutic solutions targeting two of the medical cannabis markets in the world: Canada and California.
Executives
Mark Hamish Kimmins Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)

Sunniva (XCNQ:SNN) Headlines

From GuruFocus

Smith & Nephew: A Medical Equipment Opportunity

By The City Letter 08-09-2022

Smith+Nephew acquires novel cementless partial knee system

By PRNewswire PRNewswire 01-19-2022

Smith & Nephew Is Reverting to Fair Value

By Praveen Chawla 01-25-2023